Journal article
Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction
Abstract
Purpose: The ORIGIN trial showed that daily supplementation with 1 g of n–3 fatty acids did not reduce the rate of Cardiovascular (CV) events in high risk patients with type 2 Diabetes Mellitus (DM) or IFG/IGT. This ancillary analysis of the trial is aimed to evaluate the effect of this treatment in the subgroup of patients with a recent Myocardial Infarction (MI) in whom the use of n–3 fatty acids has been previously demonstrated to be able to …
Authors
Maggioni AP; Fabbri G; Bosch J; Dyal L; Ryden LE; Gerstein HC; Yusuf S
Journal
European Heart Journal, Vol. 34, No. suppl_1,
Publisher
Oxford University Press (OUP)
Publication Date
August 2, 2013
DOI
10.1093/eurheartj/eht308.1966
ISSN
0195-668X